Typical syndromic surveillance systems have taken the first step, which is to provide a measure of the number of newly infected individuals. Costs being equal, this research suggests this was the best investment for surveillance. We hope future research with different diseases and surveillance possibilities will elucidate where money should be spent in improving surveillance practices. 